Elderly Patients With Acute Coronary Syndromes Managed Without Revascularization: Insights Into the Safety of Long-Term Dual Antiplatelet Therapy With Reduced-Dose Prasugrel vs. Standard-Dose Clopidogrel

Study Questions:

What is the efficacy and safety of reduced-dose prasugrel compared with clopidogrel in the elderly population?